"Healthy Volunteers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Persons with no known significant health problems who are recruited to participate in research to test a new drug, device, or intervention as controls for a patient group. (from http://clinicalcenter.nih.gov/recruit/volunteers.html, accessed 2/14/2013)
| Descriptor ID |
D064368
|
| MeSH Number(s) |
M01.774.500 M01.955.236
|
| Concept/Terms |
Healthy Volunteers- Healthy Volunteers
- Healthy Volunteer
- Volunteer, Healthy
- Healthy Participants
- Healthy Participant
- Participant, Healthy
- Participants, Healthy
- Healthy Subjects
- Healthy Subject
- Subject, Healthy
- Subjects, Healthy
Human Volunteers- Human Volunteers
- Human Volunteer
- Volunteer, Human
- Volunteers, Human
Normal Volunteers- Normal Volunteers
- Normal Volunteer
- Volunteer, Normal
- Volunteers, Normal
|
Below are MeSH descriptors whose meaning is more general than "Healthy Volunteers".
Below are MeSH descriptors whose meaning is more specific than "Healthy Volunteers".
This graph shows the total number of publications written about "Healthy Volunteers" by people in this website by year, and whether "Healthy Volunteers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 5 | 5 |
| 2014 | 0 | 2 | 2 |
| 2015 | 1 | 8 | 9 |
| 2016 | 0 | 7 | 7 |
| 2017 | 1 | 13 | 14 |
| 2018 | 1 | 8 | 9 |
| 2019 | 0 | 16 | 16 |
| 2020 | 0 | 12 | 12 |
| 2021 | 2 | 10 | 12 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 3 | 3 |
| 2025 | 0 | 5 | 5 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Healthy Volunteers" by people in Profiles.
-
Establishing Reference Values in Healthy Participants for the Cardiac Troponin T High-Sensitivity Gen 6 Assay: REF-TSIX Global Reference Study. Clin Chem. 2026 Apr 02; 72(4):488-502.
-
A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults. J Infect Dis. 2026 Mar 17; 233(3):e641-e645.
-
A Randomized Phase 1 Study Investigating Gut Microbiome Changes With Moxifloxacin vs Oral Vancomycin: Implications for Clostridioides difficile Risk. J Infect Dis. 2025 Dec 20; 232(6):1446-1456.
-
Faecal pharmacokinetics, microbiome, and bile acid changes in healthy subjects given intravenous followed by oral omadacycline; a Phase 1 clinical trial. J Antimicrob Chemother. 2025 Oct 03; 80(10):2719-2726.
-
Evaluation of tractography parameters for dentato-rubro-thalamic tract reconstruction during pediatric posterior fossa tumor surgery. MAGMA. 2026 Apr; 39(2):275-288.
-
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone? or Flublok?) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45?years of age. Vaccine. 2025 04 30; 54:126991.
-
Phase I trial comparing bile acid and short-chain fatty acid alterations in stool collected from human subjects treated with omadacycline or vancomycin. Antimicrob Agents Chemother. 2025 02 13; 69(2):e0125124.
-
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults. Clin Infect Dis. 2024 06 14; 78(6):1757-1768.
-
Near-infrared spectroscopy data for foot skin oxygen saturation in healthy subjects. Int Wound J. 2024 Mar; 21(3):e14814.
-
Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers. J Infect Dis. 2024 01 12; 229(1):273-281.